Alyeska Investment Group’s Solid Biosciences SLDB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.4M	Buy	2,280,125 +597,320	+35%	+$3.84M	0.05%	351
2025 Q4	$9.49M	Hold	1,682,805	–	–	0.03%	396
2025 Q3	$10.4M	Buy	1,682,805 +41,984	+3%	+$245K	0.03%	371
2025 Q2	$7.99M	Hold	1,640,821	–	–	0.03%	377
2025 Q1	$6.07M	Buy	1,640,821 +1,294,450	+374%	+$5.54M	0.02%	351
2024 Q4	$1.39M	Hold	346,371	–	–	0.01%	482
2024 Q3	$2.41M	Sell	346,371 -100,000	-22%	-$811K	0.01%	404
2024 Q2	$2.53M	Buy	446,371 +31,756	+8%	+$284K	0.01%	394
2024 Q1	$5.52M	Sell	414,615 -222,664	-35%	-$2.08M	0.03%	319
2023 Q4	$3.91M	Sell	637,279 -9,325	-1%	-$29.8K	0.03%	326
2023 Q3	$1.63M	Hold	646,604	–	–	0.01%	397
2023 Q2	$3.39M	Hold	646,604	–	–	0.03%	366
2023 Q1	$3.06M	Buy	646,604 +106,457	+20%	+$640K	0.03%	332
2022 Q4	$2.89M	Sell	540,147 -1	-0%	-$7	0.03%	297
2022 Q3	$3.74M	Buy	540,148 +442,198	+451%	+$4.46M	0.04%	283
2022 Q2	$904K	Buy	97,950 +10,000	+11%	+$104K	0.01%	502
2022 Q1	$1.58M	Buy	87,950 +20,000	+29%	+$353K	0.02%	457
2021 Q4	$1.78M	Buy	67,950 +9,040	+15%	+$276K	0.02%	457
2021 Q3	$2.11M	Buy	58,910 +24,834	+73%	+$1.05M	0.03%	490
2021 Q2	$1.87M	Hold	34,076	–	–	0.02%	529
2021 Q1	$2.83M	Buy	+34,076	New	+$3.77M	0.04%	414
2018 Q2	–	Sell	-7,457	Closed	-$839K	–	515
2018 Q1	$839K	Buy	+7,457	New	+$2.52M	0.01%	399

Other funds holding SLDB